Hoth Therapeutics Competitors and Similar CompaniesClear all

Veloxis Pharmaceuticals's competitors and similar companies include CorMedix.
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
CorMedix
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Founding Date
Founding Date
2002
Founding Date
2006
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
København, DK HQ
Cary, US
Cary, US
Locations
Berkeley Heights, US HQ
Employees
Employees
54
Employees
3036% increase

Financial

Revenue (est.)
Revenue (est.)
kr39.5m (FY, 2018)
Revenue (est.)
$311.7m (FY, 2025)
Cost of goods
Cost of goods
kr7.9m (FY, 2018)
Cost of goods
$22.1m (FY, 2025)
Gross profit
Gross profit
kr31.6m (FY, 2018)
Gross profit
$275.7m (FY, 2025)
Net income
Net income
(kr5.3m) (FY, 2018)
Net income
$163.1m (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 11.5m
For sources of this data, please see the company profile

View Company Profiles

CorMedix
HQ
Berkeley Heights, US
Employees
30↑ 36% increase

CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.

View company